Senseonics (NYSE:SENS) announced that UnitedHealthcare intends to begin providing coverage for its Eversense E3 CGM. Coverage of the continuous glucose monitor for people with type 1 and insulin-requiring type 2 diabetes goes into effect on July 1, 2023. UnitedHealthcare, the largest health insurance company in the U.S., covers more than 45 million lives. Its offerings […]
UnitedHealthcare
UnitedHealthcare to eliminate out-of-pocket costs on insulin, other prescription drugs
UnitedHealthcare announced today that it will eliminate out-of-pocket costs in standard fully insured group plans for certain prescription drugs. Insulin, among a number of drugs used to treat emergencies including severe allergic reactions, hypoglycemia, opioid overdoses, and acute asthma attacks will be included in the new standard offering. Along with insulin, epinephrine (for severe allergic […]
